Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Justine Mills"'
Autor:
Li Chen, Biswajit Das, Ting-Chia Chang, Yvonne A. Evrard, Chris A. Karlovich, Alyssa Chapman, Brandie Fullmer, Ashley Hayes, Ruth Thornton, Nikitha Nair, Shahanawaz Jiwani, Lindsay Dutko, Kelly Benauer, Gloryvee Rivera, Corinne Camalier, John Carter, Suzanne Borgel, Tiffanie Miner, Chelsea McGlynn, Justine Mills, Shannon Uzelac, Tia Shearer, Lauren Hicks, Michelle Norris, Carley Border, Sergio Alcoser, Thomas Walsh, Michael Mullendore, Michelle Eugeni, Dianne Newton, Melinda G. Hollingshead, P. Mickey Williams, James H. Doroshow
Publikováno v:
Cancer Research. 83:6072-6072
Introduction: Structural variants (SVs) are a unique class of mutations which have certain therapeutic implications for the tumor. Certain SVs, such as chromosomal aneuploidy, whole-genome doubling (WGD), have specific therapeutic implications. The u
Autor:
Thomas S. Dexheimer, Thomas Silvers, Rene Delosh, Russell Reinhart, Chad Ogle, Zahra Davoudi, Eric Jones, Debbie Trail, John Carter, Justine Mills, Kyle Georgius, Howard Stotler, Michelle Norris, Shannon Uzelac, Suzanne Borgel, Tiffanie Minor, Luke Stockwin, Michael Mullendore, Kevin Plater, Keegan Kalmbach, Jessica Steed, Matthew Murphy, Gareth Bliss, Carrie Bonomi, Kelly Dougherty, Marion Gibson, Kevin Cooper, Dianne Newton, Cindy R. Timme, Yvonne A. Evrard, Melinda G. Hollingshead, Nathan P. Coussens, Ralph E. Parchment, James H. Doroshow, Beverly A. Teicher
Publikováno v:
Cancer Research. 83:5720-5720
There is a major need in oncology drug development to establish predictive preclinical assays with high translational relevance to patient responses. The National Cancer Institute’s Patient-Derived Models Repository (https://pdmr.cancer.gov) offers
Autor:
Peter I. Wu, Lindsay Dutko, Shahanawaz Jiwani, Li Chen, Biswajit Das, Ting-Chia Chang, Yvonne A. Evrard, Chris A. Karlovich, Alyssa Chapman, Brandie Fullmer, Ashley Hayes, Ruth Thornton, Nikitha Nair, Kelly Benauer, Gloryvee Rivera, Thomas Forbes, John Carter, Suzanne Borgel, Tiffanie Miner, Chelsea McGlynn, Justine Mills, Shannon Uzelac, Tia Shearer, Lauren Hicks, Michelle Norris, Carley Border, Sergio Alcoser, Thomas Walsh, Michael Mullendore, Michelle Eugeni, Dianne Newton, Melinda G. Hollingshead, P. M. Williams, James H. Doroshow
Publikováno v:
Cancer Research. 83:2050-2050
Background: Breast cancer is the second most common cancer in women. In 2022, it accounted for 15% of total new cancer cases and is the number four cause of death among all cancer types. To benefit from precision medicine, distinguishing molecular su
Autor:
Yvonne A. Evrard, Michelle Eugeni, Michelle Ahalt-Gottholm, Carrie Bonomi, Suzanne Borgel, Thomas C. Caffrey, John Carter, Ting-Chia Chang, Li Chen, Kevin Cooper, Biswajit Das, Emily Delaney, Kelly Dougherty, Eleonora Duregon, Stephanie Ecker, Joe Geraghty, Marion Gibson, Lauren Hicks, Jenna Hull, Sharon Int Veldt, Shahanawaz Jiwani, Chris A. Karlovich, Jade Loewenstein, Candace Mallow, Chelsea McGlynn, Justine Mills, Tiffanie Miner, Jowaly Schneider, Tia Shearer, Savanna Styers, Shannon Uzelac, Paul Grandgenett, Michael Hollingsworth, Jody E. Hooper, P. Mickey Williams, Melinda Hollingshead, James H. Doroshow
Publikováno v:
Cancer Research. 82:3120-3120
NCI’s Patient-Derived Models Repository (NCI PDMR; pdmr.cancer.gov) has developed a variety of patient-derived models across most solid tumor histologies. These models are early passage, genetically characterized and associated with limited patient
Autor:
Michael Mullendore, Jenna Hull, P. Mickey Williams, Cindy R. Timme, Dianne L. Newton, Tia Shearer, Shahanawaz Jiwani, Li Chen, Chris Karlovich, Michelle Eugeni, Tara Grinnage-Polley, James H. Doroshow, Kristen Cooley, Tom Walsh, Devynn Breen, Emily Delaney, Kimberly Klarmann, Michelle M. Gottholm-Ahalt, Melinda G. Hollingshead, Jesse Stottlemyer, Chelsea McGlynn, Malorie Morris, John Mark Carter, Yvonne A. Evrard, Alice P. Chen, Ting-Chia Chang, Candace Mallow, Sergio Y. Alcoser, Shannon Uzelac, Biswajit Das, Justine Mills
Publikováno v:
Cancer Research. 81:3012-3012
There is an unmet need for preclinical models of rare cancers and rare disease sub-types. The National Cancer Institute's Patient-Derived Models Repository (NCI PDMR; https://pdmr.cancer.gov) is developing quality-controlled, early-passage, clinicall
Autor:
John Carter, Dianne L. Newton, Shannon Uzelac, Gloryvee Rivera, Michael Mullendore, Malorie Morris, Abigail Walke, Lily Chen, Thomas Forbes, Kyle Georgius, Emily Delaney, Sergio . Y. Alcoser, Debbie Trail, Tom Walsh, Raymond Divelbiss, Tara Grinnage-Pulley, Shahanawaz Jiwani, Chris Karlovich, Yvonne A. Evrard, Lyndsay Dutko, Sierra Hoffman, Devynn Breen, Biswajit Das, Howard Stotler, Rajesh Patidar, Thomas Vilimas, Peng Wang, Justine Mills, Suzanne Borgel, Nicole Walters, Melinda G. Hollingshead, James Doroshow, Savanna Styers, Jesse Stottlemyer, Tiffanie Chase, Michelle M. Gottholm-Ahalt, Alice P. Chen, Kristen Cooley, P. Mickey Williams
Publikováno v:
Cancer Research. 80:5056-5056
The National Cancer Institute's Patient-Derived Models Repository (NCI PDMR; https://pdmr.cancer.gov) is performing a large-scale multi-year preclinical study with 39 PDX models of rare cancers (mesothelioma, MPNST, osteosarcoma, Merkel cell carcinom
Autor:
Gaurav Agrawal, Justine Mills, Suhirdan Vivekanandarajah, Harriet Kingston-Smith, Annabel Clancy, Sanjay Ramrakha, Antony Wettstein, Thomas J. Borody, Vic Dawson, Simon Benstock, John Saxon, Anise Yusuf
Publikováno v:
Gastroenterology. 156:S-808